EPISODE · Mar 5, 2026 · 15 MIN
**Eli Lilly’s Zepbound Successfully Treats Sleep Apnea In Landmark Clinical Trial Results**
from AI Daily Pulse · host Healthcare Daily Pulse
Intelligence Brief:CMS Receives Record Comments on 2026 Medicare Advantage RulePK Consumer Health Acquires HealthAid in EUR 100M EBITDA PlayOverlake Medical Deploys Agentic AI for 349-Bed SystemCMS Issues 30 Warning Letters to Telehealth GLP-1 PlatformsPwC Predicts 2026 Healthcare M&A Rebound Driven by AIArdent Health Implements AI Helpers in 2000 Patient RoomsCMS Proposes 10-Year Catastrophic Plan Terms for 2027.**[START AUDIO]** **ALEX:** We’re looking at a landscape where the "move fast and break things" era just hit the brick wall of actuarial reality. I’m Alex, and this is Healthcare Daily Pulse. **Sam:** And I’m Sam. We’re coming to you from the war room where the numbers are finally catching up to the narratives. Alex, the market’s been treating healthcare tech like a software play for five years, but the Q3 earnings calls we’re seeing? They’re a wake-up call for anyone who thinks a shiny UI sol...
Embed this episode
NOW PLAYING
**Eli Lilly’s Zepbound Successfully Treats Sleep Apnea In Landmark Clinical Trial Results**
No transcript for this episode yet
Similar Episodes
No similar episodes found.